Insider Selling: Quantum-Si (NASDAQ:QSI) Insider Sells $14,506.56 in Stock

Quantum-Si Incorporated (NASDAQ:QSI) insider John Vieceli sold 15,111 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $0.96, for a total value of $14,506.56. Following the completion of the sale, the insider directly owned 1,155,546 shares of the company’s stock, valued at approximately $1,109,324.16. This represents a 1.29% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website.

Quantum-Si Stock Performance

NASDAQ QSI opened at $0.85 on Friday. The stock’s fifty day moving average is $0.99 and its two-hundred day moving average is $1.03. The firm has a market capitalization of $186.14 million, a P/E ratio of -1.68 and a beta of 3.18. Quantum-Si Incorporated has a fifty-two week low of $0.69 and a fifty-two week high of $3.10.

Quantum-Si (NASDAQ:QSI) last issued its earnings results on Thursday, May 7th. The company reported ($0.10) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.02. Quantum-Si had a negative return on equity of 47.35% and a negative net margin of 5,605.88%.The company had revenue of $0.26 million during the quarter, compared to analysts’ expectations of $0.30 million. As a group, sell-side analysts forecast that Quantum-Si Incorporated will post -0.49 EPS for the current year.

Wall Street Analysts Forecast Growth

QSI has been the subject of several recent analyst reports. Canaccord Genuity Group cut their price objective on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, March 4th. Weiss Ratings reissued a “sell (d-)” rating on shares of Quantum-Si in a research note on Wednesday. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Reduce” and an average price target of $1.00.

Hedge Funds Weigh In On Quantum-Si

Several large investors have recently modified their holdings of the business. Prudential Financial Inc. purchased a new position in shares of Quantum-Si during the 2nd quarter worth $25,000. Cerity Partners LLC purchased a new stake in Quantum-Si in the 2nd quarter valued at about $29,000. Curbstone Financial Management Corp purchased a new stake in Quantum-Si in the 4th quarter valued at about $26,000. Leonteq Securities AG acquired a new position in Quantum-Si in the fourth quarter valued at about $28,000. Finally, BNP Paribas Financial Markets lifted its position in Quantum-Si by 101.3% in the third quarter. BNP Paribas Financial Markets now owns 30,464 shares of the company’s stock valued at $43,000 after buying an additional 15,331 shares during the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si Inc is a life sciences instrumentation company headquartered in Guilford, Connecticut, developing next-generation proteomics solutions based on semiconductor sequencing technology. The company’s core offering centers on a proprietary single-molecule protein sequencing platform that uses a silicon-based sensor chip to convert protein data into digital signals. This approach is designed to deliver high sensitivity, single-amino-acid resolution and deep proteome coverage while potentially reducing cost and complexity compared to traditional mass spectrometry methods.

Quantum-Si’s product roadmap includes the development and commercialization of an integrated system comprising instruments, consumable reagents and proprietary data analysis software.